What a Peptide's Half-Life Actually Is (Plain-English Guide)

A peptide’s half-life is the time it takes your body to clear half of what is currently in your bloodstream. That is the whole definition. The confusion starts because people treat it like a countdown timer (“half-life is 5 hours, so it’s gone in 10”) when it describes a curve that keeps halving. To see the curve for any figure you enter, the Peptide Half-Life Visualizer plots single-dose clearance and reports when you cross 50%, 25%, 10%, and 1% remaining. This guide explains what that number is, the simple math behind it, and, just as important, what it does not tell you.

Half-life is a rate, not a finish line

Start with what half-life literally measures: the time for the blood concentration of a substance to fall to half its starting amount. The key word is half. After one half-life, ~50% remains. After two, ~25%. After three, ~12.5%. The compound never mathematically hits zero; it approaches it in ever-smaller steps.

Half-lives elapsed	Approx. remaining
0	100%
1	50%
2	25%
3	12.5%
4	6.25%
5	~3%

This is why a single half-life number is useful: it lets you sketch the whole decay curve from one measurement. If you know a peptide’s half-life, you know roughly how much is left at any point after a dose, without measuring again.

Why the number stays constant: first-order clearance

Most clinically relevant drugs, including the engineered peptides used in metabolic medicine, are cleared by first-order kinetics. That means the rate of elimination is proportional to how much is present: the more drug in the blood, the faster it leaves; as levels drop, clearance slows in step. The practical consequence is that the fraction removed per unit time is constant, so the half-life itself is a fixed property of the compound (in a given person), independent of the starting dose.

That constancy is what makes half-life such a portable shorthand. A higher dose reaches a higher peak, but it still halves on the same clock. Double the dose and you do not double the half-life; you just start the same curve from a taller point.

(A minority of substances follow zero-order kinetics, where a fixed amount clears per unit time regardless of concentration; alcohol is the classic example. There, “half-life” is not constant and the shorthand breaks down. The peptides discussed on this site are first-order.)

The ln2 math, briefly

You do not need the equation to use half-life, but it explains where the number comes from. For a first-order process:

t½ = 0.693 / ke

Here ke is the elimination rate constant (the fraction cleared per hour), and 0.693 is the natural logarithm of 2. It shows up because you are asking how long a two-fold decrease takes in an exponential process. Flip it around and the half-life gives you the rate constant, which is all the Visualizer needs to draw the curve. That is the entire engine behind every “how much is left” estimate.

What half-life does not tell you

This is where most misreadings happen. Half-life is one number about one thing: how fast blood levels fall. It is silent on several others:

• It is not the dose or the effect size. Two peptides with identical half-lives can require wildly different amounts and produce completely different effects. Half-life says nothing about potency.
• It is not “how long it works.” Blood clearance and biological action can diverge. A compound can be nearly gone from plasma while its effect persists, because the effect depends on receptor binding and downstream signaling, not just circulating drug. We cover this split in half-life vs duration of action.
• It is not fixed across people. Kidney and liver function, body size, and other factors shift an individual’s clearance. Published half-lives are population averages, not personal guarantees.
• It does not, by itself, set the dosing interval, though it heavily influences it. Why the same receptor target can call for daily versus weekly dosing is the subject of peptide half-life and dosing frequency.

A vivid illustration of that last point: native GLP-1, the gut hormone, has a half-life of roughly two minutes because enzymes degrade it almost instantly. The engineered GLP-1 drugs last about a week. Same receptor, half-lives that differ by a factor of thousands, which is exactly why the raw number tells you about clearance and nothing else. That contrast is the subject of why engineered GLP-1 drugs last a week.

Reading a half-life like a pro

When you see “half-life ≈ X,” translate it into three quick facts:

1. How fast blood levels fall: halving every X, so ~90% gone by a little over three half-lives, ~97% by five. (That five-half-lives shorthand gets its own treatment in the 5 half-lives rule.)
2. Roughly how often you’d redose to keep levels in a working range: short half-life leans frequent, long leans infrequent.
3. Nothing about whether it works or how strongly: that requires separate pharmacodynamic data.

Everyday substances make the same math intuitive: if you want a familiar worked example, see how long caffeine lasts, which runs the identical curve with a ~5-hour half-life.

The takeaway

A peptide’s half-life is the time to clear half of what is in your blood, and because clearance is exponential and first-order, that single number lets you reconstruct the whole decay curve, but only the curve. It is a statement about speed of removal, not about dose, strength, or duration of effect. Keep those separate and half-life becomes a useful tool instead of a source of false precision.

Plot any half-life and watch the curve fall with the Peptide Half-Life Visualizer, and use the Dose Interval Visualizer to see how repeated doses stack on top of that decay.

This article is educational information about pharmacokinetics, not medical or dosing advice. Many research peptides are not approved for human use; consult a qualified clinician before making any decision about a medication or compound.

Sources

• Elimination Half-Life of Drugs — StatPearls, NCBI Bookshelf
• GLP-1 and GLP-1 receptor agonists in the treatment of type 2 diabetes — PMC